Sign in to view content

Modulation of Macrophages and Complement Dysfunction in Nonexudative AMD Using New Sialic Acid-Coated Nanoparticles

Carl D. Regillo, MD

Video
Published 2023

Related

Preservation of Vision by ANX007: Clinical Results and Anatomic Changes From the Phase 2 ARCHER Trial
Joel Pearlman, MD, PhD
Annual Meeting Talks
2024
Dry AMD Symposium 1
Annual Meeting Talks
2020
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: AMD-Non-Neovascular

See more